Literature DB >> 10560783

Flow-mediated vasodilation and distensibility in relation to intima-media thickness of large arteries in mild essential hypertension.

M Barenbrock1, M Hausberg, M Kosch, S A Golubev, K Kisters, K H Rahn.   

Abstract

Whether endothelial dysfunction in essential hypertension is a cause or a consequence of structural vessel wall alterations is not known. The purpose of the present study was to compare flow-mediated vasodilation and mechanical vessel wall properties of large arteries between never treated mild essential hypertensive patients with normal intima-media thickness (IMT) and those exhibiting intima-media thickening. We measured brachial and carotid artery diameter and distension by Doppler frequency analysis of vessel wall movements in M-mode in ten essential hypertensive patients with normal carotid artery IMT (HYP1), in ten patients with increased IMT (HYP2), and in 13 normotensive control subjects (CON). Thereafter, we measured changes in brachial artery (BA) diameters during distal reactive hyperemia after 4 min of forearm occlusion. Nitroglycerin-mediated vasodilation was measured to assess endothelium-independent vasodilation, and BA blood flow was estimated using a pulsed Doppler system. Intima-media thickness of the carotid arteries was examined by high resolution B-mode ultrasound. IMT was 0.66 +/- 0.02 mm in the HYP1 group, 0.84 +/- 0.03 mm in the HYP2 group (P < .01 v HYP1, P < .01 v CON), and 0.71 +/- 0.04 mm in the CON group. Forearm occlusion was reduced in both the HYP1 group (3.4% +/- 3.6%, P < .01 v CON) and the HYP2 group (6.4% +/- 1.5%, P < .05 v CON) when compared with the CON group (16.5% +/- 2.8%). Nitroglycerin-mediated vasodilation and BA blood flow were not different between study groups. BA distension (as well as carotid artery distension) was significantly lower in the HYP1 group (52 +/- 6 microm, P < .05 v CON), but not in the HYP2 group (72 +/- 10 microm) when compared with the CON group (88 +/- 13 microm). The data suggest that endothelial dysfunction and reduced distensibility of large arteries in patients with essential hypertension occur in the absence of structural vessel wall alterations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560783     DOI: 10.1016/s0895-7061(99)00083-7

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Temporal heterogeneity of endothelium-dependent and -independent dilatation of brachial artery in patients with coronary artery disease.

Authors:  Attila Pálinkás; Eszter Tóth; Lucia Venneri; Fausto Rigo; Miklós Csanády; Eugenio Picano
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

2.  High urinary sodium is associated with increased carotid intima-media thickness in normotensive overweight and obese adults.

Authors:  Jennifer N Njoroge; Samar R El Khoudary; Linda F Fried; Emma Barinas-Mitchell; Kim Sutton-Tyrrell
Journal:  Am J Hypertens       Date:  2010-05-27       Impact factor: 2.689

Review 3.  Monitoring vascular health beyond blood pressure.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 4.  Aldosterone and the vasculature: mechanisms mediating resistant hypertension.

Authors:  Daniel A Duprez
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

5.  Quantitative CMR markers of impaired vascular reactivity associated with age and peripheral artery disease.

Authors:  Michael C Langham; Erin K Englund; Emile R Mohler; Cheng Li; Zachary B Rodgers; Thomas F Floyd; Felix W Wehrli
Journal:  J Cardiovasc Magn Reson       Date:  2013-02-13       Impact factor: 5.364

6.  Appropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice.

Authors:  Liz Andréa Villela Baroncini; Aguinaldo de Oliveira; Enrique Antonio Vidal; Graciliano José França; Paulo Sérgio Dalla Bona Stahlke; Alexandre Alessi; Dalton Bertolim Précoma
Journal:  Cardiovasc Ultrasound       Date:  2008-10-16       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.